406
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Adrenomedullin as a therapeutic target in angiogenesis

, , , &
Pages 1059-1072 | Published online: 16 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Diego Guidolin. (2010) The multifaceted world of angiogenesis control. Expert Opinion on Therapeutic Targets 14:11, pages 1135-1138.
Read now

Articles from other publishers (18)

Lei Dou, Enting Lu, Dongli Tian, Fangmei Li, Lei Deng & Yi Zhang. (2023) Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism. Journal of Translational Internal Medicine 11:2, pages 169-177.
Crossref
Michele Fiore, Alberto Taddia, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Salvatore Serravalle, Jessica Bandini, Filippo Spreafico, Daniela Perotti, Paola Collini, Andrea Di Cataldo, Gianandrea Pasquinelli, Francesca Chiarini, Maura Fois, Fraia Melchionda, Andrea Pession & Annalisa Astolfi. (2023) Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK). International Journal of Molecular Sciences 24:4, pages 3743.
Crossref
Himanshu Soni, Julia Bode, Chi D. L. Nguyen, Laura Puccio, Michelle Neßling, Rosario M. Piro, Jonas Bub, Emma Phillips, Robert Ahrends, Betty A. Eipper, Björn Tews & Violaine Goidts. (2020) PERK-mediated expression of peptidylglycine α-amidating monooxygenase supports angiogenesis in glioblastoma. Oncogenesis 9:2.
Crossref
Jing Jia, Haibao Zhang, Hongke Zhang, Wenbo Liu, Huicong Du, Maoguo Shu & Lin He. (2019) AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma. Scientific Reports 9:1.
Crossref
Chia Lin Chang & Sheau Yu Teddy Hsu. (2019) Development of chimeric and bifunctional antagonists for CLR/RAMP receptors. PLOS ONE 14:5, pages e0216996.
Crossref
Joan Cao, Zhou Zhu, Hui Wang, Timothy C. Nichols, Goldie Y. L. Lui, Shibing Deng, Paul A. Rejto, Todd VanArsdale, James S. Hardwick, Scott L. Weinrich & Ping Wei. (2019) Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer. Oncogene 38:21, pages 4125-4141.
Crossref
Y Chen, C Li, H Xie, Y Fan, Z Yang, J Ma, D He & L Li. (2017) Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→AKT→GSK3β→AM signaling. Oncogene 36:20, pages 2879-2888.
Crossref
Rafael U. HeissFabian B. FahlbuschJohannes JacobiChristoph Daniel, Arif B. Ekici, Nada CordasicKerstin Amann, Andrea HartnerKarl F. Hilgers. (2017) Blunted transcriptional response to skeletal muscle ischemia in rats with chronic kidney disease: potential role for impaired ischemia-induced angiogenesis. Physiological Genomics 49:4, pages 230-237.
Crossref
Laura Ochoa-Callejero, Andrea Pozo-Rodrigálvarez, Ricardo Martínez-Murillo & Alfredo Martínez. (2016) Lack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and more brain damage. Scientific Reports 6:1.
Crossref
XUE-YUAN WU, CUI-PEI HAO, MING LING, CHI-HUA GUO & WEI MA. (2015) Hypoxia-induced apoptosis is blocked by adrenomedullin via upregulation of Bcl-2 in human osteosarcoma cells. Oncology Reports 34:2, pages 787-794.
Crossref
W. Hu, P.-H. Zhou, X.-B. Zhang, C.-G. Xu & W. Wang. (2014) Roles of adrenomedullin and hypoxia-inducible factor 1 alpha in patients with varicocele. Andrologia, pages n/a-n/a.
Crossref
FENBAO LI, RUIMIN YANG, XIZHONG ZHANG, AIGUANG LIU, YONGLI ZHAO & YINGCHANG GUO. (2014) Silencing of hypoxia-inducible adrenomedullin using RNA interference attenuates hepatocellular carcinoma cell growth in vivo. Molecular Medicine Reports 10:3, pages 1295-1302.
Crossref
Gijs W.D. Landman, Peter R. van Dijk, Iefke Drion, Kornelis J.J. van Hateren, Joachim Struck, Klaas H. Groenier, Rijk O.B. Gans, Henk J.G. Bilo, Stephan J.L. Bakker & Nanne Kleefstra. (2014) Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30). Diabetes Care 37:3, pages 839-845.
Crossref
K A Kocemba, H van Andel, A de Haan-Kramer, K Mahtouk, R Versteeg, M J Kersten, M Spaargaren & S T Pals. (2013) The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis. Leukemia 27:8, pages 1729-1737.
Crossref
Ignacio M. Larrayoz, Laura Ochoa-Callejero, Josune García-Sanmartín, Carlos Vicario-Abejón & Alfredo Martínez. 2012. International Review of Cell and Molecular Biology Volume 297. International Review of Cell and Molecular Biology Volume 297 175 234 .
Giovanna Albertin, Diego Guidolin, Elisa Sorato, Barbara Oselladore, Cinzia Tortorella & Domenico Ribatti. (2011) Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells. Regulatory Peptides 172:1-3, pages 16-22.
Crossref
Kenji Kuwasako, Kazuo Kitamura, Sayaka Nagata, Tomomi Hikosaka, Yoshio Takei & Johji Kato. (2011) Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 32:7, pages 1540-1550.
Crossref
Kam-Meng Tchou-Wong, Kathrin Kiok, Zuojian Tang, Thomas Kluz, Adriana Arita, Phillip R. Smith, Stuart Brown & Max Costa. (2011) Effects of Nickel Treatment on H3K4 Trimethylation and Gene Expression. PLoS ONE 6:3, pages e17728.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.